The pharmacology of the cardiac muscle of the great veins of the rat.
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials / Q000502:physiology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D016275:Atrial Function; D001285:Atropine / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D004558:Electric Stimulation; D004594:Electrophysiology; D004837:Epinephrine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects* / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008564:Membrane Potentials / Q000502:physiology; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010121:Oxytocin / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011667:Pulmonary Veins / Q000187:drug effects* / Q000502:physiology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D014043:Tolazoline / Q000494:pharmacology; D014682:Vena Cava, Inferior / Q000187:drug effects* / Q000502:physiology*; D014683:Vena Cava, Superior / Q000187:drug effects* / Q000502:physiology*; D016276:Ventricular Function
D006584:Hexamethonium Compounds; D000804:Angiotensin II; D010656:Phenylephrine; D012701:Serotonin; D010121:Oxytocin; D001285:Atropine; D006632:Histamine; D002217:Carbachol; D011433:Propranolol; D014043:Tolazoline; D007545:Isoproterenol; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine